Finland· FI-REL-REL7583

Alevaire

A tyloxapol product, registered in Finland by Sanofi-Winthrop Production Division. The same ATC class is registered in 3 of our 19 countries.

ATC R05CA01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedAlevaireATCR05CA01REGISTER NO.FI-REL-REL7583PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Tyloxapol is registered in 3 of 19 countries.

Countries holding a registration under ATC R05CA01 (tyloxapol), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Tyloxapol · ATC R05CA01

3 / 19 countries

  • Finlandprice
  • Japan
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Manufacturer
Sanofi-Winthrop Production Division
Country
Finland (FI)
ATC code
R05CA01
ATC class
Tyloxapol
Defined daily dose
5 mg, Inhal
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ce4c3429-e765-4df8-8eb4-a2823dd23225
GET /v1/drugs/ce4c3429-e765-4df8-8eb4-a2823dd23225?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "5",
  "form": "inhalaationeste",
  "route": null,
  "ddd_unit": "mg",
  "strength": "1.25 mg/ml",
  "atc_label": "tyloksapoli",
  "ma_number": "5621",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL7583",
  "authorised_at": "1968-11-20"
}

See everything about tyloxapol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.